Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Triple agonist targeting GLP-1, GIP, and glucagon receptors
Studied for appetite regulation and metabolic function
Investigated for its effects on energy expenditure and body composition
Ongoing clinical research in obesity, type 2 diabetes, and other metabolic conditions
Triple agonist targeting GLP-1, GIP, and glucagon receptors
Studied for appetite regulation and metabolic function
Investigated for its effects on energy expenditure and body composition
Ongoing clinical research in obesity, type 2 diabetes, and other metabolic conditions